David Charles Lubner, Director of Dyne Therapeutics DYN, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $450K. The latest trade was on 06/05.

DL

DL

David Charles Lubner

Director

Company

Dyne Therapeutics DYN

First filing

23/05/25

Trades

34 trades

Buys / sales

0 / 1

12-month net buying

−$450K

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AR Arcellx	Open-market sale10b5-1 plan	01/20	01/20	6,000 sh	$75.00	$450,000	−21.7%